Table: Stella Pharma - Q1 parent results

Stella Pharma

13/08/2026 07:33

    Aug 13 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2026        Jun 30, 2025      Mar 31, 2027  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            92 mln              92 mln             1.04      
                 (+0.0 pct)          (+50.0 pct)      (+221.0 pct)  
  Operating     loss 245 mln        loss 151 mln      loss 696 mln  
  Recurring     loss 228 mln        loss 155 mln      loss 625 mln  
  Net           loss 228 mln        loss 156 mln      loss 628 mln  
  EPS           loss 6.55 yen       loss 4.60 yen    loss 17.11 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T